{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:46:58Z","timestamp":1789652818563,"version":"4.0.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was partly supported by the National Research Fund, Kenya, through the PAMOJA Hubert Curien Partnership. NMO is a scientist at the Kenya Medical Research Institute (KEMRI), Nairobi, Kenya","award":["E1767"],"award-info":[{"award-number":["E1767"]}]},{"name":"This work was partly supported by the National Research Fund, Kenya, through the PAMOJA Hubert Curien Partnership. NMO is a scientist at the Kenya Medical Research Institute (KEMRI), Nairobi, Kenya","award":["E1767"],"award-info":[{"award-number":["E1767"]}]},{"name":"This work was partly supported by the National Research Fund, Kenya, through the PAMOJA Hubert Curien Partnership. NMO is a scientist at the Kenya Medical Research Institute (KEMRI), Nairobi, Kenya","award":["E1767"],"award-info":[{"award-number":["E1767"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05486-4","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:11:14Z","timestamp":1753909874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Plasmodium falciparum parasites harbouring chloroquine-resistant but not artemisinin-resistant alleles in Busia County, Western Kenya"],"prefix":"10.1186","volume":"24","author":[{"given":"Noah Machuki","family":"Onchieku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemrod","family":"Gesusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Caspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Karani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Thiong\u2019o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Kamau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kiboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damaris","family":"Matoke-Muhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"5486_CR1","first-page":"2024","volume-title":"Addressing inequity in the global malaria response","author":"WHO. World malaria report","year":"2024","unstructured":"WHO. World malaria report. Addressing inequity in the global malaria response. Geneva: World Health Organization; 2024. p. 2024."},{"key":"5486_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207\u201311.","journal-title":"Nature"},{"key":"5486_CR3","volume-title":"Status report on artemisinin resistance and ACT efficacy","author":"WHO","year":"2021","unstructured":"WHO. Status report on artemisinin resistance and ACT efficacy. Geneva: World Health Organization; 2021."},{"key":"5486_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"5486_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5486_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2023.105460","volume":"112","author":"WA Azmi","year":"2023","unstructured":"Azmi WA, Rizki AFM, Djuardi Y, Artika IM, Siregar JE. Molecular insights into artemisinin resistance in Plasmodium falciparum: an updated review. Infect Genet Evol. 2023;112: 105460.","journal-title":"Infect Genet Evol"},{"key":"5486_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Ma L, Lim P, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5486_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-56","volume":"10","author":"A Codd","year":"2011","unstructured":"Codd A, Teuscher F, Kyle DE, Cheng Q, Gatton ML. Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure. Malar J. 2011;10: 56.","journal-title":"Malar J"},{"key":"5486_CR9","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/infdis\/jiaa562","volume":"223","author":"C Peatey","year":"2021","unstructured":"Peatey C, Chen N, Gresty K, Anderson K, Pickering P, Watts R, et al. Dormant Plasmodium falciparum parasites in human infections following artesunate therapy. J Infect Dis. 2021;223:1631\u20138.","journal-title":"J Infect Dis"},{"key":"5486_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00053-24","volume":"69","author":"D Kiboi","year":"2025","unstructured":"Kiboi D, S\u00e1 JM, Nayak A, Micchelli CE, Amin SN, Burbelo AG, et al. Isolation and characterization of Plasmodium falciparum blood-stage persisters by improved selection protocols using dihydroartemisinin alone. Antimicrob Agent Chemother. 2025;69: e0005324.","journal-title":"Antimicrob Agent Chemother"},{"key":"5486_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1126\/science.aax4735","volume":"367","author":"J Birnbaum","year":"2020","unstructured":"Birnbaum J, Scharf S, Schmidt S, Jonscher E, Hoeijmakers WAM, Flemming S, et al. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites. Science. 2020;367:51\u20139.","journal-title":"Science"},{"key":"5486_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S1473-3099(20)30493-X","volume":"21","author":"NK Kayiba","year":"2021","unstructured":"Kayiba NK, Yobi DM, Tshibangu-Kabamba E, Tuan VP, Yamaoka Y, Devleesschauwer B, et al. Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review. Lancet Infect Dis. 2021;21:82\u201392.","journal-title":"Lancet Infect Dis"},{"key":"5486_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03987-6","volume":"20","author":"A Owoloye","year":"2021","unstructured":"Owoloye A, Olufemi M, Idowu ET, Oyebola KM. Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum. Malar J. 2021;20: 451.","journal-title":"Malar J"},{"key":"5486_CR14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparumkelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"5486_CR15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana J-LM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"5486_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12936-023-04812-y","volume":"23","author":"B Jeang","year":"2024","unstructured":"Jeang B, Zhong D, Lee M-C, Atieli H, Yewhalaw D, Yan G. Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia. Malar J. 2024;23:36.","journal-title":"Malar J"},{"key":"5486_CR17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola AA, Feleke SM, Mohammed H, Brhane BG, Hennelly CM, Assefa A, et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat Microbiol. 2023;8:1911\u20139.","journal-title":"Nat Microbiol"},{"key":"5486_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","volume":"389","author":"S Mihreteab","year":"2023","unstructured":"Mihreteab S, Platon L, Berhane A, Stokes BH, Warsame M, Campagne P, et al. Increasing rrevalence of artemisinin-resistant HRP2-negative malaria in Eritrea. N Engl J Med. 2023;389:1191\u2013202.","journal-title":"N Engl J Med"},{"key":"5486_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","volume":"24","author":"DS Ishengoma","year":"2024","unstructured":"Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, et al. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. Lancet Infect Dis. 2024;24:1225\u201333.","journal-title":"Lancet Infect Dis"},{"key":"5486_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00160-5","volume":"5","author":"JJ Juliano","year":"2024","unstructured":"Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, et al. Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine\u2013pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey. Lancet Microbe. 2024;5: 100920.","journal-title":"Lancet Microbe"},{"key":"5486_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41182-024-00640-1","volume":"52","author":"M Makau","year":"2024","unstructured":"Makau M, Kanoi BN, Mgawe C, Maina M, Bitshi M, Too EK, et al. Presence of Plasmodium falciparum strains with artemisinin-resistant K13 mutation C469Y in Busia County, Western Kenya. Trop Med Health. 2024;52:72.","journal-title":"Trop Med Health"},{"key":"5486_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-106","volume":"8","author":"L Mwai","year":"2009","unstructured":"Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009;8: 106.","journal-title":"Malar J"},{"key":"5486_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4269\/ajtmh.13-0129","volume":"89","author":"JA Flegg","year":"2013","unstructured":"Flegg JA, Metcalf CJE, Gharbi M, Venkatesan M, Shewchuk T, Hopkins Sibley C, et al. Trends in antimalarial drug use in Africa. Am J Trop Med Hyg. 2013;89:857\u201365.","journal-title":"Am J Trop Med Hyg"},{"key":"5486_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1046\/j.1365-3156.2000.00643.x","volume":"5","author":"R Shretta","year":"2000","unstructured":"Shretta R, Omumbo J, Rapuoda B, Snow RW. Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health. 2000;5:755\u201364.","journal-title":"Trop Med Int Health"},{"key":"5486_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0035-9203(90)90246-B","volume":"84","author":"A Bj\u00f6rkman","year":"1990","unstructured":"Bj\u00f6rkman A, Phillips-Howard PA. The epidemiology of drug-resistant malaria. Trans R Soc Trop Med Hyg. 1990;84:177\u201380.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5486_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03454-8","volume":"19","author":"MA Pacheco","year":"2020","unstructured":"Pacheco MA, Schneider KA, Cheng Q, Munde EO, Ndege C, Onyango C, et al. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H. Malar J. 2020;19: 378.","journal-title":"Malar J"},{"key":"5486_CR27","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","volume":"187","author":"JG Kublin","year":"2003","unstructured":"Kublin JG, Cortese JF, Njunju EM, Mukadam RAG, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870\u20135.","journal-title":"J Infect Dis"},{"key":"5486_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4269\/ajtmh.2003.68.413","volume":"68","author":"T Mita","year":"2003","unstructured":"Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg. 2003;68:413\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"5486_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15031-2","volume":"7","author":"KB Beshir","year":"2017","unstructured":"Beshir KB, Sep\u00falveda N, Bharmal J, Robinson A, Mwanguzi J, Busula AO, et al. Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya. Sci Rep. 2017;7: 14718.","journal-title":"Sci Rep"},{"key":"5486_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2023.1083114","volume":"3","author":"D Okanda","year":"2023","unstructured":"Okanda D, Ndwiga L, Osoti V, Achieng N, Wambua J, Ngetsa C, et al. Low frequency of Plasmodium falciparum hrp2\/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya. Front Epidemiol. 2023;3: 1083114.","journal-title":"Front Epidemiol"},{"key":"5486_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12936-017-1752-9","volume":"16","author":"A Berhane","year":"2017","unstructured":"Berhane A, Russom M, Bahta I, Hagos F, Ghirmai M, Uqubay S. Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results. Malar J. 2017;16:105.","journal-title":"Malar J"},{"key":"5486_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.26502\/jbb.2642-91280157","volume":"7","author":"L Karani","year":"2024","unstructured":"Karani L, Otinga M, Ombati M, Osano M, Wangechi L. Performance and comparative evaluation of a novel diagnostic assay, Novaplex\u2122 malaria assay, against routine diagnostic techniques in the detection of different Plasmodium spp. in Kenya. J Biotechnol Biomed. 2024;7:338\u201349.","journal-title":"J Biotechnol Biomed"},{"key":"5486_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1475-2875-12-272","volume":"12","author":"A Baidjoe","year":"2013","unstructured":"Baidjoe A, Stone W, Ploemen I, Shagari S, Grignard L, Osoti V, et al. Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies. Malar J. 2013;12:272.","journal-title":"Malar J"},{"key":"5486_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01067-19","volume":"63","author":"K Wamae","year":"2019","unstructured":"Wamae K, Okanda D, Ndwiga L, Osoti V, Kimenyi KM, Abdi AI, et al. No evidence of Plasmodium falciparum k13 artemisinin resistance-conferring mutations over a 24-year analysis in Coastal Kenya but a near complete reversion to chloroquine-sensitive parasites. Antimicrob Agents Chemother. 2019;63: e01067\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"5486_CR35","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"5486_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5486_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66277","volume":"10","author":"BH Stokes","year":"2021","unstructured":"Stokes BH, Dhingra SK, Rubiano K, Mok S, Straimer J, Gn\u00e4dig NF, et al. Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness. Elife. 2021;10: e66277.","journal-title":"Elife"},{"key":"5486_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-120","volume":"13","author":"L Golassa","year":"2014","unstructured":"Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia. Malar J. 2014;13: 120.","journal-title":"Malar J"},{"key":"5486_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-74","volume":"9","author":"NB Gadalla","year":"2010","unstructured":"Gadalla NB, Elzaki SE, Mukhtar E, Warhurst DC, El-Sayed B, Sutherland CJ. Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Malar J. 2010;9: 74.","journal-title":"Malar J"},{"key":"5486_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10462-z","volume":"25","author":"V Osoti","year":"2025","unstructured":"Osoti V, Wamae K, Ndwiga L, Gichuki PM, Okoyo C, Kepha S, et al. Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya. BMC Infect Dis. 2025;25: 73.","journal-title":"BMC Infect Dis"},{"key":"5486_CR41","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124.","journal-title":"Science"},{"key":"5486_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature00813","volume":"418","author":"JC Wootton","year":"2002","unstructured":"Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320\u20133.","journal-title":"Nature"},{"key":"5486_CR43","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/infdis\/jir664","volume":"204","author":"T Mita","year":"2011","unstructured":"Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, et al. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis. 2011;204:1980\u20138.","journal-title":"J Infect Dis"},{"key":"5486_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijpddr.2014.07.003","volume":"4","author":"J Okombo","year":"2014","unstructured":"Okombo J, Kamau AW, Marsh K, Sutherland CJ, Ochola-Oyier LI. Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya. Int J Parasitol Drugs Drug Resist. 2014;4:152\u201363.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5486_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064299","volume":"8","author":"FL Eyase","year":"2013","unstructured":"Eyase FL, Akala HM, Ingasia L, Cheruiyot A, Omondi A, Okudo C, et al. The role of pfmdr1 and pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in Western-Kenya P. falciparum samples during 2008\u20132011. PLoS ONE. 2013;8: e64299.","journal-title":"PLoS ONE"},{"key":"5486_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijpddr.2015.05.005","volume":"5","author":"AO Achieng","year":"2015","unstructured":"Achieng AO, Muiruri P, Ingasia LA, Opot BH, Juma DW, Yeda R, et al. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether\u2013lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Int J Parasitol Drugs Drug Resist. 2015;5:92\u20139.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5486_CR47","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12936-017-2089-0","volume":"16","author":"A Musuva","year":"2017","unstructured":"Musuva A, Ejersa W, Kiptui R, Memusi D, Abwao E. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016. Malar J. 2017;16:494.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05486-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:59:11Z","timestamp":1757321951000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05486-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5486"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05486-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each study participant before study participation. This study protocol was approved by the scientific and ethics review unit (SERU) at Kenya Medical Research Institute (approval number KEMRI\/CBRD\/242\/SERU4772).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}}],"article-number":"247"}}